Therefore, the key to treating inflammatory diseases such as ALI may lie in “restraining” rather than “abolishing” NF-κB signaling to limit the inflammation while preserving its essential beneficial functions (Figure 11). Here, NFKB1 is linked to acute respiratory distress syndrome.